Skip to content

Peptide stability determines the window of usable research material. Degradation mechanisms, storage conditions, and handling practices collectively dictate shelf life and bioactivity retention.

Peptide bonds undergo hydrolytic cleavage, particularly at elevated temperatures and extreme pH.

Bond TypeSusceptibilityConditions
Asp-ProVery highMild acid, neutral pH
Asp-GlyHighAcidic conditions
Asn-GlyHighAlkaline pH
General peptide bondsModeratepH <3 or pH >9

Kinetics: Hydrolysis rate doubles for every 10°C increase (Arrhenius relationship).

Methionine and cysteine residues are primary oxidation targets:

ResidueProductConsequence
MethionineMethionine sulfoxideAltered hydrophobicity, reduced activity
CysteineCysteic acidDisulfide bond disruption
TryptophanOxindolylalanineFluorescence loss, aggregation
Histidine2-oxo-histidineCross-linking, aggregation

Mitigation: Nitrogen overlay, antioxidant excipients, amber vials.

Peptides form aggregates through multiple pathways:

PathwayTriggerPrevention
Hydrophobic interactionConcentration, temperatureDilution, cold storage
Disulfide scramblingCysteine oxidationInert atmosphere
Secondary structure formationpH, ionic strengthBuffer optimization
Surface adsorptionContainer materialLow-binding surfaces

Asparagine and glutamine residues undergo deamidation:

ResidueProductpH Dependence
AsnAsp + isoAspFaster at pH 4–6
GlnGluSlower, pH-dependent

Significance: Alters charge, structure, and potentially bioactivity.

ConditionShelf LifeNotes
2–8°C12–24 monthsStandard storage
−20°C24–60 monthsExtended storage
−80°C60+ monthsLong-term archival
Room temperatureDays–weeksShort-term only
ConditionShelf LifeNotes
2–8°C14–30 daysStandard
Room temperature24 hoursUse same day
−20°CNot recommendedFreeze-thaw damage

Each freeze-thaw cycle causes:

  • Ice crystal formation → physical stress on peptide structure
  • Concentration effects → local supersaturation during freezing
  • Surface adsorption → peptide loss to container walls
  • pH shifts → buffer component precipitation

Best practice: Aliquot into single-use volumes before freezing.

FactorImpactMitigation
Accelerated degradationArrhenius kineticsCold storage
Conformational changesThermal denaturationControlled temperature
AggregationHydrophobic exposureLow temperature
Microbial growthContaminationRefrigeration
Peptide TypeOptimal pHStability Window
Most peptides4–7pH 3–8
Acid-stable peptides2–5pH 1–6
Base-stable peptides8–10pH 7–11
Amino AcidLight SensitivityProtection
TryptophanHighAmber vials
TyrosineModerateDark storage
PhenylalanineLowStandard storage
CysteineModerateAmber vials
  • Hygroscopic lyophilized peptides absorb moisture
  • Moisture accelerates hydrolysis and aggregation
  • Store in desiccated environment
  • Use desiccant packs for lyophilized storage
ParameterAcceptableReject
ClarityClearTurbid, cloudy
ColorColorless (or specified)Yellow, brown, pink
ParticlesNoneAny visible particles
PrecipitateNoneAny sediment
MethodApplicationDetection
HPLC (RP)Purity, degradation productsUV 210–220 nm
HPLC (SEC)AggregationUV 210–220 nm
IEX-HPLCCharge variantsUV 210–220 nm
CEPurity, charge variantsUV 214 nm
MethodApplication
MALDI-TOFMolecular weight verification
ESI-MSIntact mass, modifications
LC-MS/MSPeptide mapping, modification ID
Assay TypeApplication
Cell-based potencyFunctional activity
Receptor bindingAffinity retention
In vivo efficacyBiological effect
PeptideLyophilized Shelf LifeReconstituted Shelf LifeKey Concern
Semaglutide36 months30 days at 2–8°CAggregation
Liraglutide24 months30 days at 2–8°CDeamidation
Exenatide24 monthsUse same dayHydrolysis
PeptideLyophilized Shelf LifeReconstituted Shelf LifeKey Concern
Somatropin24 months14–28 days at 2–8°CAggregation
Sermorelin24 months48 hoursHydrolysis
CJC-129524 months30 days at 2–8°COxidation
PeptideLyophilized Shelf LifeReconstituted Shelf LifeKey Concern
BPC-15724 months30 days at 2–8°CMinimal (very stable)
TB-50024 months30 days at 2–8°CAggregation
GHK-Cu24 months30 days at 2–8°CCopper complexation
  1. Allow vials to reach room temperature before opening
  2. Use aseptic technique for all reconstitutions
  3. Minimize time at room temperature
  4. Avoid repeated freeze-thaw cycles
  5. Use low-protein-binding tubes and tips
  • Record storage conditions from receipt
  • Log reconstitution date and time
  • Document any visual changes
  • Track freeze-thaw cycles
  • Note expiration dates
  • Visual inspection before each use
  • HPLC purity check for critical applications
  • Potency assay for bioactive peptides
  • Molecular weight verification for new lots
  1. USP. “United States Pharmacopeia General Chapter <1191> Stability Testing of Peptide and Protein Drug Products.” USP 2023.
  2. ICH. “Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products.” ICH Q5C 2023.